FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077792 [Registered on: 06/12/2024] Trial Registered Prospectively
Last Modified On: 23/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   EFFECT OF MUSIC THERAPY ON MATERNAL STRESS LEVELS AND VOLUME OF EXPRESSED BREAST MILK  
Scientific Title of Study   EFFECT OF MUSIC THERAPY ON MATERNAL STRESS LEVELS AND VOLUME OF EXPRESSED BREAST MILK – A PILOT RANDOMIZED CONTROLLED TRIAL 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Himang Bhardwaj 
Designation  Junior Resident 
Affiliation  JNMCH AMU  
Address  Department of Paediatrics JNMCH AMU Aligarh

Aligarh
UTTAR PRADESH
202001
India 
Phone  7351604565  
Fax    
Email  Hbhardwaj3792@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Professor Uzma Firdaus 
Designation  Professor  
Affiliation  JNMCH AMU  
Address  Department of Paediatrics JNMCH AMU Aligarh

Aligarh
UTTAR PRADESH
202001
India 
Phone  9837122711  
Fax    
Email  Druzmafirdaus@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Himang Bhardwaj 
Designation  Junior Resident 
Affiliation  JNMCH AMU  
Address  Department of Paediatrics JNMCH AMU Aligarh


UTTAR PRADESH
202001
India 
Phone  7351604565  
Fax    
Email  Hbhardwaj3792@gmail.com  
 
Source of Monetary or Material Support  
Dr Himang Bhardwaj Jr1 Department of Paediatrics Jnmch AMU ALIGARH UP India 202001 
 
Primary Sponsor  
Name  Dr Himang Bhardwaj 
Address  Department of Paediatrics JNMCH AMU Aligarh 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Himang Bhardwaj   Neonatal Intensive Care Unit  Side Room Division of Neonatology Department of Paediatrics JNMCH AMU Aligarh
Aligarh
UTTAR PRADESH 
7351604565

Hbhardwaj3792@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (Regd.),Jawaharlal Nehru Medical College and Hospita  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z391||Encounter for care and examinationof lactating mother, (2) ICD-10 Condition: P073||Preterm [premature] newborn [other],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Music Therapy  Baselines Volume of Expressed Breast Milk and Salivary cortisol levels taken before Music therapy at 6 am of same patient and Baseline Volume of Expressed Breast Milk and Salivary Cortisol level of control at 6am and 8 am 
Intervention  Music Therapy  Music Therapy is given for 30 minutes through earpods at 8 before Expression of Breast Milk and post music Salivary Cortisol 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  28.00 Day(s)
Gender  Both 
Details  Mother along with the preterm newborns admitted in Neonatal Intensive care unit. 
 
ExclusionCriteria 
Details  Sick Mothers or mothers taking any drugs which are contraindicated during lactation. 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1.To determine the effect of music therapy on reducing stress level in lactating mothers.
2.To determine the effect of music therapy on augmenting the volume of expressed breast milk and maternal stress hormone 
Early Morning (6am-9am) 
 
Secondary Outcome  
Outcome  TimePoints 
To explore the maternal and neonatal factors affecting the milk output.  Early Morning (6am-9am) 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This pilot randomized control trial will include 80 newborn mother dyads, 40 each in the intervention and the control group. A written informed consent will be sought from the parents/legal guardian. The details of newborn history, finding of clinical examination and results of investigation will be recorded in the predesigned proforma. Maternal and family characteristics, ANC details and birth related history, comorbid conditions, physical characteristics and investigation results will be meticulously enquired and entered in the proforma. Block randomization including blocks of 4 will be utilized for recruitment of subjects in the two arms.
For expression of milk in the control group, the mother will be made to sit in the designated area for 10 minutes after which expression of milk will be done by aseptic measures. For the study group, the mother will be seated in the same place and will be made to listen to a preselected light instrumental music with the help of earpods for 30 minutes. The expression of milk will be done after 20 minutes while she still keeps listening to the music adopting the same procedure as previously mentioned.
The volume of milk expressed will be quantified and fed to the baby as advised by the treating neonatologist. The trial will commence after obtaining the registration from CTRI
 
Close